>VHC413 (VHC413Q) /CSM/VH/VHC4-A/VHC413Q.Seq.d/
AAAATATTTTATTATAGTAATAAAACAAATAAAATAAACCATGTCAACAGATAATTCAGT
TACTTCTGTGGTCAAAGATATTGAACAATATGAAGTTGCAAAAAAAAAGGCAGAGGAAAT
ATTAAAAAAAGATCCATTAGCTGTAATCCCTATTGATATGTATGGAACTGTTGAAACTGA
GGATCCATTTGATATTATTGAATTTTTTACACCAACAATCGACGACATTGAAGTAGTAGC
CTCTAAATTAATCGAATCCATACCAATTGTTGGAGATGTATTAGGAGTTGTTTTTCAATT
ATTTTGGCAAAGAGCAACTGATGAGGACAAACAAAAAAAAAAAAAAANTNGGAAAAAAAA
TNGGCAAANTTNAAAAAAAAAXXXXXXXXXXATAAATCAAAGAGATTAAAATCATTGAGA
GAGAAATTACATGAAAAAATTATTGATGGTTTATCTATTATTACCGAGAATTGTCAAGAT
GCAGATATGTTGAAAAATGCTCATTTAATTTTAAAAAATGATTTAGTATTGTATCCAGTT
CCTTTGATTGTTGGCACACCAATTAAAGCAAAAGATCAATTGAAAGAAAAAATTCATGAA
CTTGATTATAGTTATGTACCAGAGATTACAATTCCTGAACATTCAATACCATTTATCTAT
CGTATGGATGCATCTTGTTTAAGACAAGATCCAAAATCTCAAAATATCTCTTCGATGAAA
CGTGATTTTAAGTATGAACCAATCTCTGGTTGTCATGGTCAATACCTATCTGGTGAATTA
TTATTAAAAGTTAATTTCCCAGATTCATTAAAAGGTAAAAAAGTTATGATTAGATTATTA
TCAATGCATGATTCAAAGTATGAAGGTAATATAAATATTTCATTTGGTAAAGAAATTGAA
CAGATTCCAATGATTAAAGAAAAAATTTCAATTTTTAGAAAAAAGGACCTTTTTTCCAGG
GTTGTTAAAAAAGTAAGTGGAATGACTTACTCTAAGAAATTCAAAATTAACAATTCCCAA
AATTTGAGTATACATCATAACTTAAGACCAGTTAAGAGATCTGACA

kyfiivikqik*TMSTDNSVTSVVKDIEQYEVAKKKAEEILKKDPLAVIPIDMYGTVETE
DPFDIIEFFTPTIDDIEVVASKLIESIPIVGDVLGVVFQLFWQRATDEDKQKKKKXXKKN
XQXXKK---

---KSKRLKSLREKLHEKIIDGLSIITENCQDADMLKNAHLILKNDLVLYPVPLIVGTPI
KAKDQLKEKIHELDYSYVPEITIPEHSIPFIYRMDASCLRQDPKSQNISSMKRDFKYEPI
SGCHGQYLSGELLLKVNFPDSLKGKKVMIRLLSMHDSKYEGNINISFGKEIEQIPMIKEK
ISIFRKKDLFSRVVKKVSGMTYSKKFKINNSQNLSIHHNLRPVKRSD

Frame A:
kifyysnktnkinhvnr*fsyfcgqry*ti*sckkkgrgnikkrsiscnpy*yvwnc*n*
gsi*yy*ifytnnrrh*sssl*inrihtncwrcirscfsiilaksn**gqtkkkkxxekk
xaxxkkk---

---inqrd*nh*ernymkkllmvylllprivkmqic*kmli*f*kmi*yciqfl*llahq
lkqkin*kkkfmnliivmyqrlqflniqyhlsivwmhlv*dkiqnlkislr*nvilsmnq
slvvmvntylvnyy*klisqih*kvkkl*ldyyqcmiqsmkvi*ifhlvkklnrfq*lkk
kfqflekrtffpgllkk*ve*ltlrnskltipki*vyiit*dqlrdlt

Frame B:
kyfiivikqik*TMSTDNSVTSVVKDIEQYEVAKKKAEEILKKDPLAVIPIDMYGTVETE
DPFDIIEFFTPTIDDIEVVASKLIESIPIVGDVLGVVFQLFWQRATDEDKQKKKKXXKKN
XQXXKK---

---*ikeikiiereit*kny*wfiyyyrelsrcryvekcsfnfkk*fsivsssfdcwhtn
*skrsierkns*t*l*lctrdyns*tfntiylsygcilfktrskiskylfdet*f*v*tn
lwlswsipiw*iiiks*fprfikr*ksyd*iiina*fkv*r*ykyfiw*rn*tdsnd*rk
nfnf*kkgpffqgc*kskwndll*eiqn*qfpkfeyts*lkts*ei*

Frame C:
nill***nk*nkpcqqiiqlllwskilnnmklqkkrqrky*kkih*l*sllicmellklr
ihlillnflhqqsttlk**pln*snpyqllemy*elffnyfgkeqlmrtnkkkkkxgkkx
gkxxkk---

---KSKRLKSLREKLHEKIIDGLSIITENCQDADMLKNAHLILKNDLVLYPVPLIVGTPI
KAKDQLKEKIHELDYSYVPEITIPEHSIPFIYRMDASCLRQDPKSQNISSMKRDFKYEPI
SGCHGQYLSGELLLKVNFPDSLKGKKVMIRLLSMHDSKYEGNINISFGKEIEQIPMIKEK
ISIFRKKDLFSRVVKKVSGMTYSKKFKINNSQNLSIHHNLRPVKRSD

                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

VHC413 (VHC413Q) /CSM/VH/VHC4-A/VHC413Q.Seq.d/                       1338   0.0
VFL457 (VFL457Q) /CSM/VF/VFL4-C/VFL457Q.Seq.d/                       1338   0.0
VFI803 (VFI803Q) /CSM/VF/VFI8-A/VFI803Q.Seq.d/                       1338   0.0
VFG466 (VFG466Q) /CSM/VF/VFG4-C/VFG466Q.Seq.d/                       1338   0.0
VFC567 (VFC567Q) /CSM/VF/VFC5-C/VFC567Q.Seq.d/                       1338   0.0
AFI287 (AFI287Q) /CSM/AF/AFI2-D/AFI287Q.Seq.d/                       1338   0.0
VFI726 (VFI726Q) /CSM/VF/VFI7-B/VFI726Q.Seq.d/                       1336   0.0
AFA815 (AFA815Q) /CSM/AF/AFA8-A/AFA815Q.Seq.d/                       1336   0.0
VFL591 (VFL591Q) /CSM/VF/VFL5-D/VFL591Q.Seq.d/                       1334   0.0
VFL475 (VFL475Q) /CSM/VF/VFL4-D/VFL475Q.Seq.d/                       1334   0.0

                                                             Score    E
Sequences producing significant alignments:                  (bits) Value  N

AC117075|AC117075.2 Dictyostelium discoideum chromosome 2 map 5201047-5455781 strain AX4, complete sequence.  1039   0.0    6
DD392012|DD392012.1 Method and nucleic acids for the improved treatment of breast cell proliferative disorders.    38   0.091  2
DD391738|DD391738.1 Method and nucleic acids for the improved treatment of breast cell proliferative disorders.    38   0.091  2
CQ807268|CQ807268.1 Sequence 718 from Patent WO2004035803.         38   0.091  2
CQ806994|CQ806994.1 Sequence 444 from Patent WO2004035803.         38   0.091  2
AC137552|AC137552.11 Medicago truncatula clone mth2-9k5, complete sequence.    40   0.11   7
AE014834|AE014834.1 Plasmodium falciparum 3D7 chromosome 10 section 6 of 7 of the complete sequence.    36   0.14   11
BX901890|BX901890.16 Zebrafish DNA sequence from clone DKEY-265J11.    42   0.16   8
AC005140|AC005140.8 Plasmodium falciparum chromosome 12 clone 3D7, *** SEQUENCING IN PROGRESS ***, 4 unordered pieces.    38   0.23   12
AC116957|AC116957.2 Dictyostelium discoideum chromosome 2 map 1685067-2090751 strain AX4, complete sequence.    36   0.27   13

                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

AC117075_74(AC117075|pid:none) Dictyostelium discoideum chromoso...   303   7e-81
AC117075_75(AC117075|pid:none) Dictyostelium discoideum chromoso...    84   8e-15
FM992688_1211(FM992688|pid:none) Candida dubliniensis CD36 chrom...    37   1.5
EU255908_3(EU255908|pid:none) Lactococcus lactis subsp. lactis c...    35   3.4
AC116305_65(AC116305|pid:none) Dictyostelium discoideum chromoso...    35   5.8
AK298356_1(AK298356|pid:none) Homo sapiens cDNA FLJ56603 complet...    34   7.6
(Q9NRY4) RecName: Full=Glucocorticoid receptor DNA-binding facto...    34   7.6
BC035541_1(BC035541|pid:none) Mus musculus glucocorticoid recept...    34   7.6
(Q91YM2) RecName: Full=Glucocorticoid receptor DNA-binding facto...    34   7.6
AF159851_1(AF159851|pid:none) Homo sapiens Rho GAP p190-A mRNA, ...    34   7.6

 psg: 0.75  gvh: 0.30  alm: 0.35  top: 0.53  tms: 0.00  mit: 0.27  mip: 0.00
 nuc: 0.27  erl: 0.00  erm: 0.20  pox: 0.00  px2: 0.00  vac: 0.00  rnp: 0.00
 act: 0.00  caa: 0.00  yqr: 0.00  tyr: 0.00  leu: 0.00  gpi: 0.00  myr: 0.00
 dna: 0.00  rib: 0.00  bac: 0.00  m1a: 0.00  m1b: 0.00  m2 : 0.00  mNt: 0.00
 m3a: 0.00  m3b: 0.00  m_ : 1.00 

	 48.0 %: nuclear
	 40.0 %: cytoplasmic
	  8.0 %: plasma membrane
	  4.0 %: mitochondrial

>> prediction for VHC413 is nuc

>VHC413F.Seq
AAAATATTTTATTATAGTAATAAAACAAATAAAATAAACCATGTCAACAGATAATTCAGT
TACTTCTGTGGTCAAAGATATTGAACAATATGAAGTTGCAAAAAAAAAGGCAGAGGAAAT
ATTAAAAAAAGATCCATTAGCTGTAATCCCTATTGATATGTATGGAACTGTTGAAACTGA
GGATCCATTTGATATTATTGAATTTTTTACACCAACAATCGACGACATTGAAGTAGTAGC
CTCTAAATTAATCGAATCCATACCAATTGTTGGAGATGTATTAGGAGTTGTTTTTCAATT
ATTTTGGCAAAGAGCAACTGATGAGGACAAACAAAAAAAAAAAAAAANTNGGAAAAAAAA
TNGGCAAANTTNAAAAAAAAANNNNNNNNNN

>VHC413Z.Seq
NNNNNNNNNNATAAATCAAAGAGATTAAAATCATTGAGAGAGAAATTACATGAAAAAATT
ATTGATGGTTTATCTATTATTACCGAGAATTGTCAAGATGCAGATATGTTGAAAAATGCT
CATTTAATTTTAAAAAATGATTTAGTATTGTATCCAGTTCCTTTGATTGTTGGCACACCA
ATTAAAGCAAAAGATCAATTGAAAGAAAAAATTCATGAACTTGATTATAGTTATGTACCA
GAGATTACAATTCCTGAACATTCAATACCATTTATCTATCGTATGGATGCATCTTGTTTA
AGACAAGATCCAAAATCTCAAAATATCTCTTCGATGAAACGTGATTTTAAGTATGAACCA
ATCTCTGGTTGTCATGGTCAATACCTATCTGGTGAATTATTATTAAAAGTTAATTTCCCA
GATTCATTAAAAGGTAAAAAAGTTATGATTAGATTATTATCAATGCATGATTCAAAGTAT
GAAGGTAATATAAATATTTCATTTGGTAAAGAAATTGAACAGATTCCAATGATTAAAGAA
AAAATTTCAATTTTTAGAAAAAAGGACCTTTTTTCCAGGGTTGTTAAAAAAGTAAGTGGA
ATGACTTACTCTAAGAAATTCAAAATTAACAATTCCCAAAATTTGAGTATACATCATAAC
TTAAGACCAGTTAAGAGATCTGACA

>VHC413P.Seq
AAAATATTTTATTATAGTAATAAAACAAATAAAATAAACCATGTCAACAGATAATTCAGT
TACTTCTGTGGTCAAAGATATTGAACAATATGAAGTTGCAAAAAAAAAGGCAGAGGAAAT
ATTAAAAAAAGATCCATTAGCTGTAATCCCTATTGATATGTATGGAACTGTTGAAACTGA
GGATCCATTTGATATTATTGAATTTTTTACACCAACAATCGACGACATTGAAGTAGTAGC
CTCTAAATTAATCGAATCCATACCAATTGTTGGAGATGTATTAGGAGTTGTTTTTCAATT
ATTTTGGCAAAGAGCAACTGATGAGGACAAACAAAAAAAAAAAAAAANTNGGAAAAAAAA
TNGGCAAANTTNAAAAAAAAA----------ATAAATCAAAGAGATTAAAATCATTGAGA
GAGAAATTACATGAAAAAATTATTGATGGTTTATCTATTATTACCGAGAATTGTCAAGAT
GCAGATATGTTGAAAAATGCTCATTTAATTTTAAAAAATGATTTAGTATTGTATCCAGTT
CCTTTGATTGTTGGCACACCAATTAAAGCAAAAGATCAATTGAAAGAAAAAATTCATGAA
CTTGATTATAGTTATGTACCAGAGATTACAATTCCTGAACATTCAATACCATTTATCTAT
CGTATGGATGCATCTTGTTTAAGACAAGATCCAAAATCTCAAAATATCTCTTCGATGAAA
CGTGATTTTAAGTATGAACCAATCTCTGGTTGTCATGGTCAATACCTATCTGGTGAATTA
TTATTAAAAGTTAATTTCCCAGATTCATTAAAAGGTAAAAAAGTTATGATTAGATTATTA
TCAATGCATGATTCAAAGTATGAAGGTAATATAAATATTTCATTTGGTAAAGAAATTGAA
CAGATTCCAATGATTAAAGAAAAAATTTCAATTTTTAGAAAAAAGGACCTTTTTTCCAGG
GTTGTTAAAAAAGTAAGTGGAATGACTTACTCTAAGAAATTCAAAATTAACAATTCCCAA
AATTTGAGTATACATCATAACTTAAGACCAGTTAAGAGATCTGACA